Clinical Trails & Bio therapeutics

Clinical Bio therapeutic aspects including study drug formulations, drug design, drug-drug interactions, QT assessment, immunogenicity, comparability, special populations (hepatic and liver failure), PK and PD, regulatory expectations of PK and PD characterization, as well as reviewing factors which influence the ADME of Bio therapeutics. The objectives of early clinical development of therapeutic proteins are the same as for small molecules i.e. to investigate the molecule in a manner that will gain necessary knowledge about its tolerability safety pharmacokinetics (PK) and if possible pharmacodynamics (PD) effects in the most appropriate human populations while simultaneously protecting their safety. However, there are specific features of proteins that must be considered when designing clinical pharmacology studies.

 

  • Discovery & Preclinical Testing
  • Clinical Study Designs
  • Data Collection & Quality Control
  • Advanced Information Technology in Clinical trials
  • Clinical Trial Protocol

Related Conference of Clinical Trails & Bio therapeutics

April 17-18, 2023

35th Nano Congress for Future Advancements

Paris, France
June 19-20, 2023

3rd World Conference on Aerospace Engineering

New York, USA
June 26-27, 2023

40th Global Summit on Nanoscience and Technology

Tokyo, Japan
July 05-06, 2023

40th Global Nanotechnology Congress

Paris, France
August 14-15, 2023

26th World Nanotechnology Congress

Dublin, Ireland
September 27-28, 2023

32nd International Conference on Nanomedicine & Drug Delivery

Zurich, Switzerland
October 16-17, 2023

34th World Nano Conference

Vancouver, Canada
November 08-09, 2023

4th World Congress on Nanotechnology and Advanced Materials

Budapest, Hungary
December 04-05, 2023

31st International Conference on Nanomedicine and Nanomaterials

Prague, Czech Republic

Clinical Trails & Bio therapeutics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in